Explore patent oppositions filed by Mylan against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Jul 24, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Compositions And Uses For Treating Multiple SclerosisBIOGEN IDEC MAJul 20, 2022
Crystalline Dapagliflozin HydrateSANDOZOct 22, 2020
Methods To Mobilize Progenitor/Stem CellsGENZYMEMay 4, 2020
Low Frequency Glatiramer Acetate TherapyYEDA RESEARCHMar 25, 2019
Dosing Regimen For Multiple SclerosisYEDA RESEARCHMar 25, 2019
Aqueous Pharmaceutical Compositions Containing Borate-Polyol ComplexesALCON RESEARCHApr 19, 2018
N3 Alkylated Benzimidazole Derivative As Mek InhibitorARRAY BIOPHARMAApr 19, 2018
Aqueous Pharmaceutical Compositions Containing Borate-Polyol ComplexesALCON RESEARCHFeb 28, 2018
Pharmaceutical Compositions Having Desirable BioavailabilityALCON RESEARCHFeb 9, 2018
Pharmaceutical Composition Having Desirable BioavailabilityALCON RESEARCHJan 26, 2018

Explore Mylan's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 24, 2025
Patent NumberGrant DateTitleTotal Oppositions
Jan 2, 2019Stabilized Transdermal Drug Delivery System1
Jun 6, 2018Methods For Reducing Accumulation Of Lactate During Culturing And Method For Producing Polypeptide1
Jan 10, 2018Novel Polymorphic Forms Of Perindopril (L)-Arginine And Process For The Preparation Thereof2